File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Effects of Nonpharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong Kong

TitleEffects of Nonpharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong Kong
Authors
Keywords2019 novel coronavirus disease
COVID-19
Hong Kong
SARS-CoV-2
coronavirus disease
Issue Date2022
PublisherUS Department of Health and Human Services, Centers for Disease Control and Prevention. The Journal's web site is located at http://www.cdc.gov/ncidod/EID/index.htm
Citation
Emerging Infectious Diseases, 2022, v. 28 n. 1, p. 62-68 How to Cite?
AbstractTo determine the effects of nonpharmaceutical interventions (NPIs) for coronavirus disease on pediatric hospitalizations for infection with respiratory viruses other than severe acute respiratory syndrome coronavirus 2, we analyzed hospital data for 2017–2021. Compared with 2017–2019, age-specific hospitalization rates associated with respiratory viruses greatly decreased in 2020, when NPIs were in place. Also when NPIs were in place, rates of hospitalization decreased among children of all ages for infection with influenza A and B viruses, respiratory syncytial virus, adenovirus, parainfluenza viruses, human metapneumovirus, and rhinovirus/enterovirus. Regression models adjusted for age and seasonality indicated that hospitalization rates for acute febrile illness/respiratory symptoms of any cause were reduced by 76% and by 85%–99% for hospitalization for infection with these viruses. NPIs in Hong Kong were clearly associated with reduced pediatric hospitalizations for respiratory viruses; implementing NPIs and reopening schools were associated with only a small increase in hospitalizations for rhinovirus/enterovirus infections.
Persistent Identifierhttp://hdl.handle.net/10722/309896
ISSN
2023 Impact Factor: 7.2
2023 SCImago Journal Rankings: 2.117
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChiu, SS-
dc.contributor.authorCowling, BJ-
dc.contributor.authorPeiris, JSM-
dc.contributor.authorChan, ELY-
dc.contributor.authorWong, WHS-
dc.contributor.authorLee, KP-
dc.date.accessioned2022-01-10T09:15:26Z-
dc.date.available2022-01-10T09:15:26Z-
dc.date.issued2022-
dc.identifier.citationEmerging Infectious Diseases, 2022, v. 28 n. 1, p. 62-68-
dc.identifier.issn1080-6040-
dc.identifier.urihttp://hdl.handle.net/10722/309896-
dc.description.abstractTo determine the effects of nonpharmaceutical interventions (NPIs) for coronavirus disease on pediatric hospitalizations for infection with respiratory viruses other than severe acute respiratory syndrome coronavirus 2, we analyzed hospital data for 2017–2021. Compared with 2017–2019, age-specific hospitalization rates associated with respiratory viruses greatly decreased in 2020, when NPIs were in place. Also when NPIs were in place, rates of hospitalization decreased among children of all ages for infection with influenza A and B viruses, respiratory syncytial virus, adenovirus, parainfluenza viruses, human metapneumovirus, and rhinovirus/enterovirus. Regression models adjusted for age and seasonality indicated that hospitalization rates for acute febrile illness/respiratory symptoms of any cause were reduced by 76% and by 85%–99% for hospitalization for infection with these viruses. NPIs in Hong Kong were clearly associated with reduced pediatric hospitalizations for respiratory viruses; implementing NPIs and reopening schools were associated with only a small increase in hospitalizations for rhinovirus/enterovirus infections.-
dc.languageeng-
dc.publisherUS Department of Health and Human Services, Centers for Disease Control and Prevention. The Journal's web site is located at http://www.cdc.gov/ncidod/EID/index.htm-
dc.relation.ispartofEmerging Infectious Diseases-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subject2019 novel coronavirus disease-
dc.subjectCOVID-19-
dc.subjectHong Kong-
dc.subjectSARS-CoV-2-
dc.subjectcoronavirus disease-
dc.titleEffects of Nonpharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong Kong-
dc.typeArticle-
dc.identifier.emailChiu, SS: ssschiu@hku.hk-
dc.identifier.emailCowling, BJ: bcowling@hku.hk-
dc.identifier.emailPeiris, JSM: malik@hkucc.hku.hk-
dc.identifier.emailChan, ELY: laiyin@hkucc.hku.hk-
dc.identifier.emailWong, WHS: whswong@hku.hk-
dc.identifier.emailLee, KP: lee1965@hkucc.hku.hk-
dc.identifier.authorityChiu, SS=rp00421-
dc.identifier.authorityCowling, BJ=rp01326-
dc.identifier.authorityPeiris, JSM=rp00410-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.3201/eid2801.211099-
dc.identifier.pmid34932446-
dc.identifier.pmcidPMC8714236-
dc.identifier.scopuseid_2-s2.0-85121681571-
dc.identifier.hkuros331362-
dc.identifier.volume28-
dc.identifier.issue1-
dc.identifier.spage62-
dc.identifier.epage68-
dc.identifier.isiWOS:000746318000008-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats